(21 days)
Pisces Quad Model 3487A, Pisces Quad Compact Model 3887, Pixees Quad Plus Model 3888, Pisces Z Quad Model 3890, Pisces Z Quad Compact Model 3891, Pisces Z Quad Plus Model 3892, Specify Model 3998, Pisces Octad Model 3898, SymMix Model 3982A, Temporary Screening Lead Model 3861, and Verify Model 3862 are indicated for Spinal Cord Stimulation to aid in the management of chronic intractable pain of the trunk and/or limbs.
Resume II Model 35874 and Resume TL Model 3986A are indicated for Spinal Cord Stimulation to aid m the management of chronic intractable pain of the trunk and/or limbs. They are also indicated for Peripheral Nerve Stimulation. The peripheral nerve stimulators are used to stimulate electrically a peripheral nerve in patients to relieve severe intractable pain.
On-Point Model 39874 is indicated for Peripheral Nerve Stimulation. The peripheral nerve stimulators are used to stimulate electrically a peripheral nerve in patients to relieve severe intractable pain.
Resume II 3587A, Resume TL 3986A, On-Point 3987A, and SymMix 3982A are quadripolar implantable neurostimulation surgical leads with in-line connector.
Pisces Quad 3487A, Pisces Quad Compact 3887, and Pisces Quad Plus 3888 are percutaneous quadripolar implantable neurostimulation leads.
Pisces Z Quad 3890, Pisces Z Quad Compact 3891, and Pisces Z Quad Plus 3892 are low impedance percutaneous quadripolar implantable neurostimulation leads.
Pisces Octad 3898 is a percutaneous octapolar implantable neurostimulation lead.
Temporary screening lead 3861 is a percutaneous bipolar implantable neurostimulation lead to be used for no more than 10 days.
Verify 3862 is a percutaneous quadripolar implantable neurostimulation lead to be used for no more than 10 days.
Specify 3998 is an octapolar implantable ncurostimulation surgical lead.
The provided document is a 510(k) summary for Medtronic Neurostimulation Leads. It focuses on establishing substantial equivalence to predicate devices rather than providing detailed performance data from a clinical study with acceptance criteria.
The document states:
-
D. Performance Data: "Performance data that supports the safety and effectiveness of the modified neurostimulation leads are included in this 510(k) premarket notification." However, this summary does not include the specific performance data or any acceptance criteria that would typically be associated with a clinical trial or algorithm performance study.
-
E. Conclusion: "Medtronic neurostimulation leads (list of leads) are substantially equivalent to the noted predicate devices based on the similarities of technological characteristics, the identical indications for use, and the results of the testing." This reinforces that the submission aims for substantial equivalence based on testing results (not specified in detail here) and technological characteristics, not necessarily against predefined performance acceptance criteria for a novel device.
Therefore, based solely on the provided text, it is not possible to fill out the requested table regarding acceptance criteria and device performance, nor can questions 2-9 be answered.
The submission is for a medical device (neurostimulation leads), which typically involves rigorous engineering and biocompatibility testing, but this type of 510(k) summary often does not detail the specific pass/fail criteria or results for each test. It focuses on the conclusion of substantial equivalence.
If this were a submission for an AI/ML-driven diagnostic or prognostic device, the requested information would be critical and typically present. However, for physical medical devices seeking 510(k) clearance via substantial equivalence, the "performance data" often refers to bench testing, biocompatibility, and electrical safety, which would be compared to standards and predicate device data rather than defined clinical performance metrics like sensitivity, specificity, or reader improvement.
{0}------------------------------------------------
MAR 2 5 2004
K040568
1 of 3
510(k) Summary Medtronic Neurostimulation Leads (as required by 21 CFR 807.92)
Medtronic Neurological
710 Medtronic Parkway NE
Minneapolis, Minnesota 55432-5604 USA
A. Submitter information
Submitter's Name:
Address:
Telephone Number
Contact Person:
Doug Atkins
763.505.0204
Date Submission Prepared:
February 27, 2004
B. Device Information
| Device Trade Name: | Pisces Z Quad® lead kit for Spinal Cord Stimulation (SCS) |
|---|---|
| Pisces Z Quad Compact™ lead kit for Spinal Cord Stimulation (SCS) | |
| Pisces Z Quad Plus® lead kit for Spinal Cord Stimulation (SCS) | |
| Pisces Quad® lead kit for Spinal Cord Stimulation (SCS) | |
| Pisces Quad® Compact lead kit for Spinal Cord Stimulation (SCS) | |
| Pisces Quad® Plus lead kit for Spinal Cord Stimulation (SCS) | |
| Pisces Octad® lead kit for Spinal Cord Stimulation (SCS) | |
| Specify™ lead kit for Spinal Cord Stimulation (SCS) | |
| Resume II® lead kit for Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) | |
| Resume® TL lead kit for Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) | |
| SymMix® lead kit for Spinal Cord Stimulation (SCS) | |
| On-Point® lead kit for Peripheral Nerve Stimulation (PNS) | |
| Verify® lead kit for Spinal Cord Stimulation (SCS) | |
| Temporary Screening Lead for Spinal Cord Stimulation (SCS) | |
| Common or Usual Name: | Spinal Cord Stimulation Lead |
| Peripheral Nerve Stimulation Lead | |
| Classification Name: | Implanted spinal cord stimulator for pain relief (21 CFR 882.5880) |
| Implanted peripheral nerve stimulator for pain relief (21 CFR 882.5870) |
Image /page/0/Picture/14 description: The image shows the Medtronic logo with the word "Medtronic" in bold, black letters. To the left of the word is a circular logo with a stick figure inside. Below the word "Medtronic" is the word "Confidential" in a smaller font.
{1}------------------------------------------------
K040568
2023
Classification Code:
Predicate Device:
Device Description:
GZB-Spinal Cord Stimulators GZF—Peripheral Nerve Stimulators
Pisces Quad 3487A-K923931 Pisces Quad Compact 3887-K923931 Pisces Quad Plus 3888-K923567 Pisces Z Quad 3890-K033016 Pisces Z Quad Compact 3891-K033016 Pisces Z Quad Plus 3892—K033016 Specify 3998-K971756 Pisces Octad 3898-K934065 Resume II 3587A-K032561 SymMix 3982A-K032561 Resume TL 3986A-K032561 On-Point 3987A-K032561 Temporary Screening Lead 3861-K912764 Verify 3862--K932202
Resume II 3587A, Resume TL 3986A, On-Point 3987A, and SymMix 3982A are quadripolar implantable neurostimulation surgical leads with in-line connector.
Pisces Quad 3487A, Pisces Quad Compact 3887, and Pisces Quad Plus 3888 are percutaneous quadripolar implantable neurostimulation leads.
Pisces Z Quad 3890, Pisces Z Quad Compact 3891, and Pisces Z Quad Plus 3892 are low impedance percutaneous quadripolar implantable neurostimulation leads.
Pisces Octad 3898 is a percutaneous octapolar implantable neurostimulation lead.
Temporary screening lead 3861 is a percutaneous bipolar implantable neurostimulation lead to be used for no more than 10 days.
Verify 3862 is a percutaneous quadripolar implantable neurostimulation lead to be used for no more than 10 days.
Specify 3998 is an octapolar implantable ncurostimulation surgical lead.
Pisces Quad Model 3487A, Pisces Quad Compact Model 3887, Pisces Quad Plus Model 3888, Pisces Z Quad Model 3890, Pisces Z Quad Compact Model 3891, Pisces Z Quad Plus Model 3892, Specify Model 3998, Pisces Octad Model 3898, SymMix Model 3982A, Temporary Screening Lead Model 3861, and Verify Model 3862 are indicated for Spinal Cord Stimulation to aid in the management of chronic intractable pain of the trunk and/or limbs.
Image /page/1/Picture/13 description: The image shows the Medtronic logo. The logo consists of a symbol on the left and the word "Medtronic" on the right. Below the word "Medtronic" is the word "Confidential". The symbol on the left appears to be a person in motion inside of a circle.
Indications for Use:
{2}------------------------------------------------
Image /page/2/Picture/0 description: The image shows handwritten text that appears to be a combination of letters and numbers. The text includes 'K040568' and '3 of 3'. The writing is in black ink and has a somewhat rough or潦草 appearance.
Resume II Model 3587A and Resume TL Model 3986A are indicated for Spinal Cord Stimulation to aid in the management of chronic intractable pain of the trunk and/or limbs. They are also indicated for Peripheral Nerve Stimulation. The peripheral nerve stimulators are used to stimulate electrically a peripheral nerve in patients to relieve severe intractable pain.
On-Point Model 3987A is indicated for Peripheral Nerve Stimulation. The peripheral nerve stimulators are used to stimulate electrically a peripheral nerve in patients to relieve severe intractable pain.
C. Comparison of Required Technological Characteristics
The technological characteristics of the modified leads for neurostimulation are substantially equivalent to the noted predicate devices.
D. Performance Data
Performance data that supports the safety and effectiveness of the modified neurostimulation leads are included n this 510(k) premarket notification.
E. Conclusion
Medtronic neurostimulation leads (Pisces Quad 3487A, Pisces Quad Compact 3887, Pisces Quad Plus 3888, Pisces Z Quad 3890, Pisces Z Quad Compact 3891, Pisces Z Quad Plus 3892, Specify 3998, Pisces Octad 3898, SymMix 3982A, Temporary Screening Lead 3861, Verify 3862, Resume II 3587A, Resume TL 3986A, and On-Point 3987A) are substantially equivalent to the noted predicate devices based on the similarities of technological characteristics, the identical indications for use, and the results of the testing.
Image /page/2/Picture/9 description: The image shows the Medtronic logo with the word "Medtronic" in bold, black letters. To the left of the word is a circular symbol with abstract shapes inside. Below the word "Medtronic" is the word "Confidential" in a smaller, less bold font.
{3}------------------------------------------------
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 5 2004
Doug Atkins Regulatory Affairs Specialist 710 Medtronic Parkway NE Minneapolis, Minnesota 55432-5604
Re: K040568
Trade/Device Name: Pisces Z Quad®, Pisces Z Quad Compact™, Pisces Z Quad Plus®, Pisces Quad®, Pisces Quad® Compact, Pisces Quad® Plus, Pisces Octad®, Specify™, Resume® II, Resume® TL, SymMix®, Verify® and Temporary Screening Lead
Regulation Number: 21 CFR 882.5880 Regulation Name: Implanted Spinal Cord Stimulator for Pain Relief Regulatory Class: Class II Product Code: GZB
Trade/Devicc Name: Resume® II, Resume® TL and On-Point® Regulation Number: 21 CFR 882.5870 Regulation Name: Implanted Peripheral Nerve Stimulator for Pain Relief Regulatory Class: Class II Product Code: GZF
Dated: March 3, 2004 Received: March 5, 2004
Dear Mr. Atkins:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the cnactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
{4}------------------------------------------------
Page 2 - Mr. Doug Atkins
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.qov/cdrh/dsma/dsmamain.html
Sincercly vours.
Mark N. Milliman
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Indications for Use
510(k) Number (if known):
Device Name: Pisces 7 Quad® lead
Pisces Z Quad Compact™ lead Pisces Z Quad Plus® lead Pisces Quad® lead Pisces Quad® Compact Icad Pisces Quad® Plus lead Pisces Octad® lead Specify™ lead Resume II® lead Resume® TL lead SymMix® lead On-Point® lead
Indications for Use:
Pisces Quad Model 3487A, Pisces Quad Compact Model 3887, Pixees Quad Plus Model 3888, Pisces Z Quad Model 3890, Pisces Z Quad Compact Model 3891, Pisces Z Quad Plus Model 3892, Specify Model 3998, Pisces Octad Model 3898, SymMix Model 3982A, Temporary Screening Lead Model 3861, and Verify Model 3862 are indicated for Spinal Cord Stimulation to aid in the management of chronic intractable pain of the trunk and/or limbs.
Resume II Model 35874 and Resume TL Model 3986A are indicated for Spinal Cord Stimulation to aid m the management of chronic intractable pain of the trunk and/or limbs. They are also indicated for Peripheral Nerve Stimulation. The peripheral nerve stimulators are used to stimulate electrically a peripheral nerve in patients to relieve severe intractable pain.
On-Point Model 39874 is indicated for Peripheral Nerve Stimulation. The peripheral nerve stimulators are used to stimulate electrically a peripheral nerve in patients to relieve severe intractable pain.
Prescription Use × (Part 21 CFR 801 Subpart D)
Confidential
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER
PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
for Mark N. Milkeran
(Division Sign-off)
Division of General, Restorative,
and Neurological Devices
510(k) Number. K040568
Page 1 of 1
Medtronic
§ 882.5880 Implanted spinal cord stimulator for pain relief.
(a)
Identification. An implanted spinal cord stimulator for pain relief is a device that is used to stimulate electrically a patient's spinal cord to relieve severe intractable pain. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.(b)
Classification. Class II (performance standards).